These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 30273552)
21. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration. Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730 [TBL] [Abstract][Full Text] [Related]
22. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP Minter MR; Hinterleitner R; Meisel M; Zhang C; Leone V; Zhang X; Oyler-Castrillo P; Zhang X; Musch MW; Shen X; Jabri B; Chang EB; Tanzi RE; Sisodia SS Sci Rep; 2017 Sep; 7(1):10411. PubMed ID: 28874832 [TBL] [Abstract][Full Text] [Related]
23. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease. Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677 [TBL] [Abstract][Full Text] [Related]
24. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors. Takeda S Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962 [TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease and amyloid: culprit or coincidence? Skaper SD Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834 [TBL] [Abstract][Full Text] [Related]
26. Copper and Alzheimer's Disease. Mathys ZK; White AR Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269 [TBL] [Abstract][Full Text] [Related]
27. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model. Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821 [TBL] [Abstract][Full Text] [Related]
28. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms. Dehghani R; Rahmani F; Rezaei N Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357 [TBL] [Abstract][Full Text] [Related]
30. Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease. El Gaamouch F; Liu K; Lin HY; Wu C; Wang J Neurochem Int; 2021 Jul; 147():105046. PubMed ID: 33872681 [TBL] [Abstract][Full Text] [Related]
31. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians. Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650 [TBL] [Abstract][Full Text] [Related]
32. Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability. Takamatsu Y; Ho G; Waragai M; Wada R; Sugama S; Takenouchi T; Masliah E; Hashimoto M J Alzheimers Dis; 2019; 68(2):473-481. PubMed ID: 30741673 [TBL] [Abstract][Full Text] [Related]
33. Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease. Fülöp T; Munawara U; Larbi A; Desroches M; Rodrigues S; Catanzaro M; Guidolin A; Khalil A; Bernier F; Barron AE; Hirokawa K; Beauregard PB; Dumoulin D; Bellenger JP; Witkowski JM; Frost E CNS Drugs; 2020 Jul; 34(7):673-695. PubMed ID: 32458360 [TBL] [Abstract][Full Text] [Related]
34. Developing Trojan horses to induce, diagnose and suppress Alzheimer's pathology. Aziz AA; Amtul Z Pharmacol Res; 2019 Nov; 149():104471. PubMed ID: 31590012 [TBL] [Abstract][Full Text] [Related]
35. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease. Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770 [TBL] [Abstract][Full Text] [Related]
36. Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration. Zhang C; Aida M; Saggu S; Yu H; Zhou L; Rehman H; Jiao K; Liu R; Wang L; Wang Q Sci Adv; 2024 Jun; 10(25):eadn8709. PubMed ID: 38905345 [TBL] [Abstract][Full Text] [Related]
37. Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives. Imbimbo BP; Lozupone M; Watling M; Panza F Expert Opin Investig Drugs; 2020 Sep; 29(9):919-933. PubMed ID: 32657175 [TBL] [Abstract][Full Text] [Related]
38. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein. Coria F; Castaño EM; Frangione B Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021 [TBL] [Abstract][Full Text] [Related]
39. A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease. Barron M; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC Exp Gerontol; 2017 Aug; 94():103-107. PubMed ID: 27979768 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages. Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]